Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 3Other solid neoplasm 2Other 2Head & Neck 2Gynecologic 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Localized Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 86pembrolizumab 76Specimen Handling 75enzalutamide 55Radiosurgery 55Radiotherapy 51Docetaxel 50Androgen Antagonists 47Gemcitabine 42Nivolumab 39darolutamide 37Prednisone 35enfortumab vedotin 32Abiraterone Acetate 31Cisplatin 30Biopsy 30Carboplatin 29cabozantinib 28Standard of Care 28apalutamide 27Pluvicto 26abiraterone 25Blood Specimen Collection 25Radiation 23Leuprolide 23Ipilimumab 22X-Rays 18relugolix 17Triptorelin Pamoate 17Surveys and Questionnaires 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Tablets × Genitourinary × Clear all
NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting
135 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡